Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, how much funding the Government provided for research into kidney disease in each financial year since 2019-20; and whether she plans to increase that funding in future years.

UK Research and Innovation (UKRI) funds research into the detection, prevention, treatment and underpinning biology of kidney disease, allocated primarily through the Medical Research Council (MRC). Over the period of 2019/20 to 2021/22, MRC has invested over £20 million in funding and support for kidney disease research with £7.7 million in 2019/20, £7.8 million in 2020/21 and £6.7 million in 2021/22.

UKRI funds research and innovation on a competitive basis, with individual applications being assessed by independent experts. In general, funding is not ring-fenced for specific conditions, and so an estimate for future spend on kidney disease research is unavailable.